XNCR earnings date and last-quarter result: last quarter beat, P/E -8.52. Updated 2026-07-23.
Xencor (XNCR) Research Hub
Xencor (XNCR) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 29.18 USD (+15.89%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -8.52, market cap 1.42B. This hub links to the full technical, earnings and options research available for XNCR.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 29.18 USD (+15.89%) |
| 52-week range | 11.99 USD – 33.58 USD |
| Trend regime | Range |
| 14-day RSI | 70.2 (Overbought) |
| Trailing P/E | -8.52 |
| Market cap | 1.42B |
| Dividend yield | 0.00% |
Available research for XNCR
Covered Call on XNCR: how it works, illustrative setup around the real 29.18 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on XNCR: how it works, illustrative setup around the real 29.18 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on XNCR: how it works, illustrative setup around the real 29.18 USD price, max profit/loss, breakeven and when to use it. Educational.
XNCR technical analysis: range, last 29.18 USD, RSI 70.2, 52w range 11.99 USD–33.58 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is XNCR in?
Xencor (XNCR) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is XNCR in an uptrend or downtrend?
As of 2026-10-26, XNCR is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is XNCR's trailing P/E ratio?
XNCR's trailing P/E is -8.52, with a market cap of 1.42B. See the earnings research page for full valuation detail.